Conceptual Definition of SGLT2 Inhibitors: FHIR Resource Sharing

Details

This document defines the conceptual group (ConceptualExposureDefinition) for SGLT2 inhibitors as an InterventionDefinition using a FHIR Group Resource and publishes it on the FEvIR platform. Although no specific inclusion/exclusion criteria or member list is set, its importance lies in providing standardized information about this drug class. The intended use of this resource is 'Evidence Communication,' which assumes sharing information for clinical research and guideline creation. By utilizing FHIR, an international healthcare data exchange standard, it becomes possible to standardize the handling of drug information across different EHR systems and research platforms. The definition was provided by Computable Publishing and noted as being created using a MAGIC-to-FEvIR Converter. This demonstrates a case study where knowledge about specific therapeutic agents is packaged into a reusable data structure compliant with international standards (FHIR), contributing to the foundation of information sharing in the medical IT field. The definition has an 'Active' status and can link with future related resources and composition reports, enabling management of more complex clinical evidence. This serves as a reference for building standard datasets in Japan's advanced EHR systems and regional health information networks.